Regulatory approval to Entod Pharma for PresVu, meant to treat presbyopia, was revoked as the firm marketed it as a 'replacement for reading glasses' & due to possible health risks.
All India Ophthalmological Society has set up expert group to review PresVu & develop guidelines on side-effects, keeping in mind 'potential inappropriate marketing, indiscriminate use'.
The eye drop, made by Entod Pharmaceuticals, was launched Tuesday in India under the brand name PresVu. but it will have no impact on near-sightedness or myopia.'
Launched Tuesday by Entod Pharmaceuticals under brand name PresVu, eye drop will treat presbyopia, an age-related condition causing blurry vision. To be available across India by October.
SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.
Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.
COMMENTS